Published in J Med Microbiol on April 01, 1988
Unusually large number of methicillin-resistant Staphylococcus aureus clones in a Portuguese hospital. J Clin Microbiol (1995) 1.21
Nosocomial infection by Staphylococcus haemolyticus and typing methods for epidemiological study. J Clin Microbiol (1994) 1.08
Antigenic and genetic homogeneity of Streptococcus uberis strains from the bovine udder. Epidemiol Infect (1991) 0.80
An association between sudden infant death syndrome (SIDS) and Helicobacter pylori infection. Arch Dis Child (2000) 8.02
Outbreak of systemic Candida albicans in intensive care unit caused by cross infection. Br Med J (Clin Res Ed) (1985) 2.74
Application of polymerase chain reaction to fingerprinting Aspergillus fumigatus by random amplification of polymorphic DNA. J Clin Microbiol (1993) 2.34
Immunoblot analysis of the serological response in systemic candidosis. Lancet (1984) 1.90
Is Bordetella pertussis clonal? BMJ (1992) 1.59
Isolation of immunodominant antigens from sera of patients with systemic candidiasis and characterization of serological response to Candida albicans. J Clin Microbiol (1987) 1.58
Autoantibody to heat-shock protein 90 can mediate protection against systemic candidosis. Immunology (1991) 1.49
Evaluation of the Ramco latex agglutination test in the early diagnosis of systemic candidiasis. Eur J Clin Microbiol (1985) 1.20
Control of an outbreak of systemic Candida albicans. Br Med J (Clin Res Ed) (1985) 1.19
Invasive aspergillosis: clusters and sources? J Med Vet Mycol (1994) 1.15
Immunoblot analysis of serological responses in invasive aspergillosis. J Clin Pathol (1985) 1.12
Use of immunoblotting to identify antigenic differences between the yeast and mycelial phases of Candida albicans. J Clin Pathol (1985) 1.10
"Pseudoclusters" and typing by random amplification of polymorphic DNA of Aspergillus fumigatus. J Clin Pathol (1995) 1.10
Four outbreaks of nosocomial systemic candidiasis. Epidemiol Infect (1987) 1.01
Outbreak of coagulase negative staphylococcus highly resistant to ciprofloxacin in a leukaemia unit. BMJ (1989) 1.00
Hospital outbreaks with yeasts. J Hosp Infect (1991) 0.99
Clamped homogeneous electric field gel electrophoresis typing of Torulopsis glabrata isolates causing nosocomial infections. J Clin Microbiol (1992) 0.97
Stress proteins in fungal diseases. Med Mycol (1998) 0.97
Candida and hands. J Hosp Infect (1986) 0.94
Candida inconspicua, a fluconazole-resistant pathogen in patients infected with human immunodeficiency virus. Clin Infect Dis (1997) 0.94
The application of epitope mapping in the development of a new serological test for systemic candidosis. J Immunol Methods (1991) 0.93
Mechanisms of anaesthesia. Lancet (1981) 0.92
Immunoblot analysis of the serological response in invasive Trichosporon beigelii and Blastoschizomyces capitatus infections. J Clin Microbiol (1986) 0.91
Identification of an immunodominant drug efflux pump in Burkholderia cepacia. J Antimicrob Chemother (2002) 0.91
Karyotyping of fluconazole-resistant yeasts with phenotype reported as Candida krusei or Candida inconspicua. Int J Syst Bacteriol (1996) 0.91
Kitchens as a source of Aspergillus niger infection. J Hosp Infect (1996) 0.90
Characterisation and cellular localisation of the immunodominant 47-Kda antigen of Candida albicans. J Med Microbiol (1988) 0.88
Cluster of clinical isolates of epidemic methicillin-resistant Staphylococcus aureus (EMRSA) with a negative deoxyribonuclease (DNase) test-implications for laboratory diagnosis and infection control. J Hosp Infect (2002) 0.85
The efficacy of acquired humoral and cellular immunity in the prevention and therapy of experimental fungal infections. Med Mycol (2000) 0.84
Immunoblot analysis of serological response to Pseudomonas aeruginosa septicaemia in man. J Clin Pathol (1986) 0.84
Epitope mapping Candida albicans proteinase (SAP 2). FEMS Immunol Med Microbiol (1997) 0.80
The Bpel locus encodes type III secretion machinery in Bordetella pertussis. Microb Pathog (1999) 0.80
Cloning and sequencing the endocarditis immunodominant antigen of Streptococcus sobrinus strain MUCOB 263. J Med Microbiol (1994) 0.80
Survival after rupture of the oesophagus and subsequent candidal endocarditis: use of new serological methods in management. Eur Heart J (1989) 0.79
Epitope mapping human heat shock protein 90 with sera from infected patients. FEMS Immunol Med Microbiol (1994) 0.79
Recurrent Escherichia coli bacteraemia in a patient with chronic renal failure. Nephrol Dial Transplant (2001) 0.78
A polymerase chain reaction enzyme immunoassay for diagnosing infection caused by Aspergillus fumigatus. J Clin Pathol (1999) 0.78
Analysis of antibody response to Cryptococcus neoformans in five patients with AIDS and cryptococcosis by immunoblotting. J Infect (2000) 0.77
Characterization of the antibody response in Corynebacterium jeikeium septicaemias. Epidemiol Infect (1990) 0.77
A PCR-based approach to sequence the Candida tropicalis HSP90 gene. FEMS Immunol Med Microbiol (2000) 0.77
Immunoblotting and culture positive endocarditis. J Clin Pathol (1991) 0.77
Comparison of three typing methods for clinical and environmental isolates of Aspergillus fumigatus. J Clin Microbiol (1995) 0.77
Clinical applications of molecular biology to diagnostic microbiology. J Clin Pathol (1992) 0.76
Intervertebral infection due to Candida albicans in an intravenous heroin abuser. Ann Rheum Dis (1988) 0.76
Ciprofloxacin-resistant Staphylococcus epidermidis and hands. Lancet (1997) 0.75
Is it time to stop searching for MRSA? Constant vigilance is needed to halt the emergence of resistance to vancomycin. BMJ (1997) 0.75
Chylopericardium, chylothorax, and hypobetalipoproteinaemia. Br Med J (Clin Res Ed) (1986) 0.75
Human recombinant antibody to HSP90: a natural partner in combination therapy. Curr Mol Med (2005) 0.75
Pulmonary problems of the immunocompromised patient. Br Med J (Clin Res Ed) (1981) 0.75
Sensitive and universal method for microbial DNA extraction from blood products. J Clin Pathol (1996) 0.75
An outbreak of imipenem-resistant Pseudomonas aeruginosa in an intensive care unit. J Hosp Infect (2004) 0.75
Human recombinant antibodies and immunotherapy. FEMS Immunol Med Microbiol (1994) 0.75
Analysis of the antibody response developing in an infant with Candida albicans meningitis. J Infect (1986) 0.75
Molecular mechanisms of general anaesthesia. Anaesthesia (1981) 0.75
New developments in the serological diagnosis of Candida infection. Mykosen Suppl (1988) 0.75
47 kD antigen of Candida albicans. Lancet (1985) 0.75
New developments in the serological diagnosis of Candida infection. Mycoses (1988) 0.75
Contamination of microscope slides with Aspergillus glaucus group A: a laboratory problem in the diagnosis of suspected mycotic infections. J Clin Pathol (1997) 0.75